Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: General Anesthesia With ETT vs LMA in Patients Undergoing Ablation for Atrial Fibrillation [NA]
Clinical trial comparing general anesthesia with endotracheal tube versus laryngeal mask airway in patients undergoing ablation for atrial f…
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Comparison of Two Strategies for the Management of Atrial Fibrillation After Cardiac Surgery [Phase 4]
Phase 4 clinical trial comparing two management strategies for atrial fibrillation after cardiac surgery.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients. [NA]
Completed clinical trial evaluating how heart rate limitation affects exercise tolerance in pacemaker patients with chronic heart failure an…
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)
Post-market clinical study update for Amplatzer Amulet shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)
Clinical trial update on vernakalant (MK-6621-049) evaluating normal use, dosing, and IV safety in atrial fibrillation; study completed with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Comparison of Efficacy and Safety of Different Doses of Nifekalant Instant Cardioversion of Persistent Atrial Fibrillation During Radiofrequency Ablation [Phase 4]
A Phase 4 clinical trial comparing varying doses of nifekalant for instant cardioversion in persistent atrial fibrillation during radiofrequ…
-
FDA approval · 2019-12-11FDA Approved: DOFETILIDE — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for dofetilide submitted by NorthStar RxLLC (ANDA210466), indicating changes to the generic prod…
-
FDA approval · 2019-11-21FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Labratories Inc.)
The FDA approved a supplemental application for Amiodarone hydrochloride from Dr. Reddy's Laboratories, enabling the generic product's marke…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Clinical Study for Workflow and Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System for Treating Symptomatic Paroxysmal AF (QDOT-Micro) [NA]
Clinical trial update announcing completion and posted results for the QDOT-Micro study evaluating the THERMOCOOL SMARTTOUCH SF-5D System in…
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness [NA]
A completed clinical trial update for the DURABLE-I study on dielectric unravelling of radiofrequency ablation effectiveness in atrial fibri…
-
FDA approval · 2019-11-14FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for propafenone hydrochloride from Rising Pharma Holdings, providing a generic version of the an…
-
FDA approval · 2019-11-13FDA Approved: PROCAINAMIDE HYDROCHLORIDE — Supplemental Application (International Medication Systems, Limited)
FDA approved a supplemental application for Procainamide hydrochloride from International Medication Systems, Limited.
-
FDA approval · 2019-11-13FDA Approved: PROPAFENONE HCL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Propafenone HCl, marking the approval of a generic Propafenone hydrochloride product from Actavi…
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation. [NA]
A completed clinical study assessing the safety and acute performance of the THERMOCOOL SMARTTOUCH SF-5D System with Fast Ablation Mode for …
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)
A completed clinical trial evaluating treatment convenience in patients treated with dabigatran for stroke prophylaxis in atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: The IPED (Investigation of Palpitations in the ED) Study [NA]
Clinical trial update for the IPED study (Investigation of Palpitations in the ED) has completed with posted results.
-
FDA approval · 2019-10-31FDA Approved: WARFARIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Warfarin Sodium (Warfarin) from Amneal Pharmaceuticals LLC.
-
FDA approval · 2019-10-31FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Propafenone Hydrochloride from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2019-10-30FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for propafenone hydrochloride, a generic antiarrhythmic drug. This approval s…
-
FDA approval · 2019-10-29FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Amiodarone Hydrochloride from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: Bolus vs IVP (Intravenous Push) Diltiazem for Atrial Fibrillation or Flutter [Phase 4]
Phase 4 clinical trial comparing bolus versus intravenous push diltiazem for atrial fibrillation or flutter with rapid ventricular response;…
-
CLINICAL_TRIALS trial_result · 2019-10-16Clinical Trial Update: Topera C-FIRM Registry
Registry update for the Topera C-FIRM device in atrial fibrillation; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: Topera E-FIRM Registry
Clinical trial registry update for the Topera E-FIRM Registry in atrial fibrillation, with results posted after completion.
-
FDA approval · 2019-10-04FDA Approved: DIGOXIN — Original Application (VistaPharm, LLC)
The FDA approved VistaPharm’s original (ANDA) application for digoxin, granting marketing approval for a generic digoxin product.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Sequential Expansion of Comparative Effectiveness of Anticoagulants
A completed clinical trial update examining the comparative effectiveness of anticoagulants in atrial fibrillation.